EMD: Group of leading Polish retailers intends to join EMD, Europe’s leading buying and marketing group
- EMD-Membership brings new sourcing opportunities for Grupa Eurocash, Grupa Chorten and Netto
- Strong presence in Poland strengthens EMD’s international market position

Pfäffikon/Switzerland, 18/07/2025: Strong Polish local retailers such as Grupa Eurocash (Delikatesy Centrum, Lewiatan, Duży Ben, Eurocash Sieci Partnerskie (abc, groszek, Euro sklep), Partnerski System Detaliczny (gama)), Grupa Chorten and Netto intend to establish a local joint-venture buying alliance to join European Marketing Distribution (EMD) AG, the leading European buying alliance. The final accession will be subject to the prior merger clearance.
Thanks to their new EMD membership, the new Polish members will be able to increase their European sourcing capabilities, generating significant savings from their supply chain which will be reinvested in strengthening their proposition to their customers.
The new EMD member to be created by Grupa Eurocash, Grupa Chorten and Netto is to be the notable buying group in Poland with a combined market presence of around 20’000 stores across the country with the combined annual turnover of approximately over 12 billion Euro which consider them #2 in retail sales in Poland.
Subject to the merger clearance from the Polish competition authority and establishment of the Polish joint-venture company, the new members will join EMD’s joint sourcing of Private Label products and EMD’s offer of on-top services to international A-brand manufacturers from 2026 on.
Pawel Surowka, Eurocash’s Chief Executive Officer: “We are extremely pleased to become a member of the strong and partnership-based EMD community. EMD offers us many product ranges and marketing instruments which will enable us to further accelerate our customer-oriented growth in the Polish market.”
For all manufacturers operating in the field of Fast Moving Consumer Goods (FMCG), the new EMD partnership opens up new opportunities.
While EMD and its member companies focus on the procurement and marketing of successful private label products, EMD members united in the EMD Retail Group also implement cross-border services and marketing concepts in partnership with leading multinational A-brand manufacturers.
In the EMD Retail Group, the Polish buying alliance, subject to the antimonopoly clearance, will collaborate from 2026 on with selected prominent and successful retail companies in their respective home countries, including the Euromadi Alfa Group from Spain, ESD Italia, Superunie from the Netherlands, RTG International, a German group of retailers, and retailer Axfood from Sweden, who also will join the group in 2026.
The core tasks for the EMD Retail Group members and new member are clearly defined: promoting and marketing established and highly sought-after top brand products (including country-specific innovations and variations of these A-brands) that are essential for customers in international retail. The EMD Retail Group cooperates with the most renowned manufacturers in the industry, including these A-brands.
Philippe Gruyters, Managing Director of EMD: ‘The new EMD membership of the Polish buying alliance opens up new sourcing opportunities for it and our existing members. With the Polish buying alliance joining our international on-top business, we can further expand our strong offering in the very dynamic Polish market.'
About EMD:
European Marketing Distribution AG, headquartered in Pfäffikon, Switzerland, has been recognised in the consumer goods industry as an efficient and powerful partner for fast-moving consumer goods (FMCG) since 1989. In particular, it develops and procures highly efficient and sustainably produced private label concepts for the benefit of consumers. The EMD head office also supports and realises global partnerships in the area of on-top agreements with the largest brand manufacturers.
Including the associate member Lotte from South Korea, the EMD member companies in Europe and Asia currently represent an external retail consumer turnover of approx. 200 billion euros in 16 countries.
The member companies of European Marketing Distribution (EMD) are active in the following markets:
|
Austria: MARKANT |
Netherlands: Superunie |
|
Belgium: Colruyt |
Norway: Unil/NorgesGruppen |
|
Czech Republic: MARKANT |
Portugal: EuromadiPort |
|
Denmark: Dagrofa |
Slovakia: MARKANT |
|
France: Francap |
South Korea: Lotte |
|
Germany: RTG International |
Spain: Euromadi |
|
Italy: ESD Italia |
Sweden: Dagab/Axfood |
|
Luxemburg: Colruyt |
Switzerland: MARKANT |
In addition to South Korea and Japan, associate member Lotte is also active in the Vietnamese and Indonesian markets.
For further information:
Donati & Rosmanith
Uwe Rosmanith
Triq ir-Rumani, 3
Xlendi, XLN1431
Malta
Phone: +356 77362849
Phone: +49 171 9706644
uwe@rosmanith.de
rosmanith@bettercommunications.mt
Images
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Acousia Announces Completion of Patient Enrollment in Phase 2 PROHEAR Study Evaluating ACOU085 (INN: Bimokalner) for the Prevention of Cisplatin-Induced Ototoxicity8.1.2026 09:00:00 CET | Press release
Tübingen, Germany, January 8, 2026 Acousia Therapeutics GmbH, a clinical-stage biotechnology company developing treatments for acute and chronic inner ear hearing loss, announced the completion of patient enrollment in its Phase 2 PROHEAR clinical study. ACOU085 (INN: Bimokalner) is a proprietary, first-in-class small molecule that has demonstrated robust and reproducible efficacy across multiple preclinical hearing loss models, including drug-induced ototoxicity. The PROHEAR Study is a double-blind, randomized, placebo-controlled, split-body, multicenter Phase 2 trial. It enrolled young male patients with metastatic testicular cancer who are scheduled to receive cisplatin-based chemotherapy. While cisplatin is a highly effective chemotherapeutic agent, cumulative doses of ≥300 mg/m² lead to clinically meaningful, permanent hearing loss in the majority of patients. Fifteen leading university hospitals in Germany are participating in this interdisciplinary study. Patients are randomized
Dr. Stefanie Kesting appointed as CEO of Thyssengas7.1.2026 14:06:26 CET | Press release
Dortmund, 06.01.2026 As of January 1, 2026, Dr. Stefanie Kesting has been appointed as the new Chief Executive Officer (CEO) of Thyssengas GmbH. She succeeds Dr. Thomas Gößmann, who will retire at the end of February 2026 after nearly nine years at the helm of the company. The leadership transition was announced in autumn 2025.
30 Years of European Spas: Nature, Natural Remedies and Climate Health as Europe’s Unique Strength7.1.2026 08:59:31 CET | Press release
To mark its 30th anniversary, the European Spas Association (ESPA) has released a special commemorative publication highlighting the strategic role of Europe’s medical spas and climate-health resorts in an era defined by prevention, longevity and sustainable wellbeing.
Forum for a self-reliant and self-determined Europe - the "Sovereign Europe Forum"23.12.2025 08:40:47 CET | Press release
Entrepreneurs, top managers and leaders from United Europe e.V. and European Forum Alpbach (EFA) are founding the Sovereign Europe Forum i.G.
Digital Subsidiary of Austrian State Printing Company Wins Infrastructure Tender for German EU Digital Identity Wallet22.12.2025 15:12:30 CET | Press release
youniqx Identity, a digital subsidiary of the Austrian State Printing Company (OSD), has won a Europe-wide tender, together with partner companies, for the infrastructure of the German EU Digital Identity Wallet (EUDI-Wallet). EU member states are required by EU regulations to provide a national version of an EU-wide valid EUDI-Wallet by the end of 2026. Citizens will be able to use the EUDI-Wallet to prove their personal identity throughout the EU
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom